Annotation Detail
Information
- Associated Genes
- FGFR3
- Associated Variants
-
FGFR3 p.Ser249Cys (p.S249C)
(
ENST00000412135.7,
ENST00000340107.9,
ENST00000440486.8,
ENST00000352904.6,
ENST00000481110.7 )
FGFR3 p.Ser249Phe (p.S249F) ( ENST00000340107.9, ENST00000352904.6, ENST00000412135.7, ENST00000440486.8, ENST00000481110.7 )
FGFR3 p.Gly372Cys (p.G372C) ( ENST00000340107.9, ENST00000352904.6, ENST00000412135.7, ENST00000440486.8, ENST00000481110.7 )
FGFR3 p.Ser249Cys (p.S249C) ( ENST00000340107.9, ENST00000352904.6, ENST00000412135.7, ENST00000440486.8, ENST00000481110.7 )
FGFR3 p.Ser249Phe (p.S249F) ( ENST00000340107.9, ENST00000352904.6, ENST00000412135.7, ENST00000440486.8, ENST00000481110.7 )
FGFR3 p.Gly372Cys (p.G372C) ( ENST00000340107.9, ENST00000352904.6, ENST00000412135.7, ENST00000440486.8, ENST00000481110.7 ) - Associated Disease
- THANATOPHORIC DYSPLASIA, TYPE I (disorder)
- Source Database
- DisGeNET
- Description
- When the results of the FGFR3 thanatophoric dysplasia mutations located in exon 7, A248C and S249C and in exon 10, G372C and T375C, were analyzed one by one or as a group, despite the findings of previous research reports, our data suggest that these mutations are detected homogenously regardless of the tumor classification and tumor grade.
- Pubmed
- 21264819
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.456557954196898
- Year of publication
- 2011
Drugs